Novo Holdings A/S - FREELINE THERAPEUTICS HLDGS ownership

FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 21 filers reported holding FREELINE THERAPEUTICS HLDGS in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Novo Holdings A/S ownership history of FREELINE THERAPEUTICS HLDGS
ValueSharesWeighting
Q4 2021$3,518,000
-46.5%
1,776,613
-7.9%
0.17%
-50.9%
Q3 2021$6,575,000
-65.8%
1,928,157
-18.3%
0.34%
-60.2%
Q2 2021$19,244,000
-33.7%
2,361,2290.0%0.85%
-28.8%
Q1 2021$29,043,000
-32.6%
2,361,2290.0%1.20%
-35.1%
Q4 2020$43,116,000
+315.3%
2,361,229
+255.1%
1.85%
+258.8%
Q3 2020$10,381,000665,0000.52%
Other shareholders
FREELINE THERAPEUTICS HLDGS shareholders Q3 2021
NameSharesValueWeighting ↓
CHI Advisors LLC 1,379,843$11,246,0002.62%
Novo Holdings A/S 2,361,229$19,244,0000.85%
Ally Bridge Group (NY) LLC 401,747$3,274,0000.81%
SECTORAL ASSET MANAGEMENT INC 640,714$5,222,0000.42%
FRAZIER MANAGEMENT LLC 550,000$4,483,0000.41%
TFG Asset Management GP Ltd 750,000$6,113,0000.33%
Eventide Asset Management 2,485,656$19,757,0000.26%
AXA S.A. 1,111,510$9,058,0000.01%
Woodline Partners LP 25,932$211,0000.00%
WELLINGTON MANAGEMENT GROUP LLP 2,001,951$16,315,0000.00%
View complete list of FREELINE THERAPEUTICS HLDGS shareholders